Diligence memo · auto-generated · as of July 2, 2026

WinProbe Corp

WinProbe Corp looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

WinProbe Corp operates in Other Health Care, based in NORTH PALM BEACH.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

WinProbe Corp has raised $417K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $317K on 2016-08-17.

Most recent recorded round closed around 2016-08-17.

Valuation (modeled)modeled

Provath models WinProbe Corp at approximately $9.8M (range $198K–$111M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.90× the median modeled value of Pre-Seed Other Health Care companies in 2016–2018 (299 peers) — value vs value, same stage and era. Within the normal band (90% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 85 months.

Last raise 9.9 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 3.2× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 18% of Other Health Care peers (5377 compared).

Modeled value ranks above 34% of those peers.

Closest niche peers: PortCo, LP, Brogent International LLC, ShiftWizard, Inc., Audio Bionics International Inc., USRC East Dallas, LLC.

Peoplefiled

7 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.